AzTrials
AzTrials

Postoperative DeliriumNCT04292561

Intraoperative EEG Monitoring and Postoperative Delirium in Elderly Patients With Sevoflurane Anesthesia

A study testing Low MAC and High MAC in people with Postoperative Delirium and Sevoflurane, run by The First Affiliated Hospital of Anhui Medical University at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Delirium is an acute onset of attentional and cognitive impairment. BIS guided anesthesia can reduce the incidence of postoperative delirium. Long term electroencephalogram (EEG) suppression during operation is related to postoperative delirium. Read more about this study

Who is it for?
Ages 60 to 90 years
What is being tested?
Low MAC and High MAC
Could I receive a placebo?
No, everyone receives an active treatment
How many people
460 participants
Where
1 siteChina
Study dates
1 Mar 2020to 10 Feb 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 to 90 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Clinical diagnosis of gastrointestinal diseases
  • Patients were aged 60 to 90 years
  • American Society of Anesthesiologists (ASA) risk classification II-IV
  • Patients were scheduled to undergo elective major abdominal operation(with a anticipated time of 2-6 h)

Who cannot join

  • Preoperative dementia or cognitive impairment
  • Mental instability or mental illness
  • Patients with any factors affecting cognitive assessment, such as language, vision and hearing impairment
  • Any cerebrovascular accident occurred within 3 months, such as stroke etc
  • Previous history of delirium
  • Known hypersensitivity to sevoflurane or history of malignant hyperthermia
  • Abuse of narcotic sedative and analgesic drugs
  • Those who have reoperation within 7 days after operation

Trial locations and contacts

1 site in 1 country.

China1 site
  • The First Affiliated Hospital of Anhui Medical University

    Hefei, Anhui, 230022

Other trials in China

About this study

Official title: Effects of Different Sevoflurane Concentrations on Intraoperative EEG and Postoperative Delirium in Elderly Patients

Delirium is an acute onset of attentional and cognitive impairment. BIS guided anesthesia can reduce the incidence of postoperative delirium. Long term electroencephalogram (EEG) suppression during operation is related to postoperative delirium. The latest research shows that the anesthesia depth guided by EEG does not reduce the incidence of postoperative delirium. The purpose of this study was to explore the relationship between anesthesia exposure with different minimum alveolar concentration(MAC) and postoperative delirium(POD), and to observe the characteristics of EEG.

Read the detailed description

More and more studies have focused on the relationship between EEG inhibition and postoperative delirium in general anesthesia. At present, there are two kinds of commonly processed quantitative EEG monitoring to evaluate the depth of anesthesia, one is bispectral index (BIS) and the other is patient state index (PSI). The relationship between intraoperative anesthetic exposure and postoperative delirium is unclear, or whether potential patient characteristics increase the risk of EEG suppression and postoperative delirium.

Gastrointestinal surgery can lead to long-term changes in colonic flora, which can remotely regulate brain function through the gut brain axis. We speculated that the abnormal composition of intestinal flora before abdominal operation might be the influencing factor of POD.

Being tested
Low MAC, High MAC
Medical subject headings
Emergence Delirium

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Low MACDrug

    To maintain a target of sevoflurane inhalation concentration 0.8 MAC.

  • High MACDrug

    To maintain a target of sevoflurane inhalation concentration 1.0 MAC.

Study groups in NCT04292561
Study groupRoleWhat they receive
light general anesthesiaExperimentalDuring anesthesia maintenance, patients were received with low concentration sevoflurane to maintain a target of 0.8 MAC.
Receives: Drug: Low MAC
deep general anesthesiaExperimentalDuring anesthesia maintenance, patients were received with high concentration sevoflurane to maintain a target of 1.0 MAC.
Receives: Drug: High MAC

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Incidence of POD

    Incidence of POD after surgery

    Measured: The 1st day after the surgery

  2. Incidence of POD

    Incidence of POD after surgery

    Measured: The 2nd day after the surgery

  3. Incidence of POD

    Incidence of POD after surgery

    Measured: The 3rd day after the surgery

  4. Incidence of POD

    Incidence of POD after surgery

    Measured: The 5th day after the surgery

  5. Incidence of POD

    Incidence of POD after surgery

    Measured: The 7th day after the surgery

Secondary outcomes (5)
  1. EEG burst inhibition

    Frequency of EEG burst inhibition

    Measured: During surgery

  2. EEG burst inhibition

    Duration of EEG burst inhibition

    Measured: During surgery

  3. Incidence of adverse events

    Incidence of adverse events after surgery

    Measured: 30-day after surgery

  4. length of stay

    length of stay after surgery

    Measured: From 1st day after the surgery to 2 weeks

  5. 30-day mortality

    30-day mortality after surgery

    Measured: 30-day after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Mar 2020
  2. Study start1 Mar 2020
  3. Primary completion30 Jan 2023
  4. Study completion10 Feb 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
460 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04292561
Sponsor's protocol ID
201912
Status last verified
Mar 2022
First submitted
8 Jan 2020
Last updated
24 Feb 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Chaput AJ, Bryson GL. Postoperative delirium: risk factors and management: continuing professional development. Can J Anaesth. 2012 Mar;59(3):304-20. doi: 10.1007/s12630-011-9658-4. Epub 2012 Feb 4. English, French.

    PubMed 22311257
  • Chan MT, Cheng BC, Lee TM, Gin T; CODA Trial Group. BIS-guided anesthesia decreases postoperative delirium and cognitive decline. J Neurosurg Anesthesiol. 2013 Jan;25(1):33-42. doi: 10.1097/ANA.0b013e3182712fba.

    PubMed 23027226
  • Fritz BA, Kalarickal PL, Maybrier HR, Muench MR, Dearth D, Chen Y, Escallier KE, Ben Abdallah A, Lin N, Avidan MS. Intraoperative Electroencephalogram Suppression Predicts Postoperative Delirium. Anesth Analg. 2016 Jan;122(1):234-42. doi: 10.1213/ANE.0000000000000989.

    PubMed 26418126
  • Wildes TS, Mickle AM, Ben Abdallah A, Maybrier HR, Oberhaus J, Budelier TP, Kronzer A, McKinnon SL, Park D, Torres BA, Graetz TJ, Emmert DA, Palanca BJ, Goswami S, Jordan K, Lin N, Fritz BA, Stevens TW, Jacobsohn E, Schmitt EM, Inouye SK, Stark S, Lenze EJ, Avidan MS; ENGAGES Research Group. Effect of Electroencephalography-Guided Anesthetic Administration on Postoperative Delirium Among Older Adults Undergoing Major Surgery: The ENGAGES Randomized Clinical Trial. JAMA. 2019 Feb 5;321(5):473-483. doi: 10.1001/jama.2018.22005.

    PubMed 30721296
  • Ridaura V, Belkaid Y. Gut microbiota: the link to your second brain. Cell. 2015 Apr 9;161(2):193-4. doi: 10.1016/j.cell.2015.03.033.

    PubMed 25860600

Questions about this trial

What is this clinical trial studying?

A study testing Low MAC and High MAC in people with Postoperative Delirium and Sevoflurane, run by The First Affiliated Hospital of Anhui Medical University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Feb 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Incidence of POD (time frame: The 1st day after the surgery). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04292561, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Feb 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in